Antje-Christine Walz

7PUBLICATIONS
17CO-AUTHORS
Haematological tumoursMolecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)Pharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Dec 28, 2021
Pharmacokinetics and Pharmacodynamics of T-Cell Bispecifics in the Tumour Interstitial Fluid.

Miro Julian Eigenmann, Tine Veronica Karlsen, Marek Wagner

|Dec 04, 2021
A Novel Approach for Quantifying the Pharmacological Activity of T-Cell Engagers Utilizing In Vitro Time Course Experiments and Streamlined Data Analysis.

Arthur Van De Vyver, Miro Eigenmann, Meric Ovacik

|Jul 19, 2021
Targeting intracellular WT1 in AML with a novel RMF-peptide-MHC-specific T-cell bispecific antibody.

Christian Augsberger, Gerulf Hänel, Wei Xu

|Jun 24, 2021
Cytokine Release Syndrome By T-cell-Redirecting Therapies: Can We Predict and Modulate Patient Risk?

Arthur J Van De Vyver, Estelle Marrer-Berger, Ken Wang

|Dec 10, 2020
Predicting Tumor Killing and T-Cell Activation by T-Cell Bispecific Antibodies as a Function of Target Expression: Combining In Vitro Experiments with Systems Modeling.

Arthur J Van De Vyver, Tina Weinzierl, Miro J Eigenmann

|Nov 16, 2019
Predicting In Vivo Efficacy from In Vitro Data: Quantitative Systems Pharmacology Modeling for an Epigenetic Modifier Drug in Cancer.

Mehdi Bouhaddou, Li J Yu, Serena Lunardi

Pageof 2

Frequent Collaborators

2 joint publications

Miro Julian Eigenmann

2 joint publications

Arthur J Van De Vyver

2 joint publications

Christian Klein

1 joint publications

Mehdi Bouhaddou